GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cargo Therapeutics Inc (NAS:CRGX) » Definitions » Price-to-Owner-Earnings

CRGX (Cargo Therapeutics) Price-to-Owner-Earnings : (As of May. 14, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Cargo Therapeutics Price-to-Owner-Earnings?

As of today (2025-05-14), Cargo Therapeutics's share price is $3.97. Cargo Therapeutics does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Cargo Therapeutics's Price-to-Owner-Earnings or its related term are showing as below:


CRGX's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 28.9
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-14), Cargo Therapeutics's share price is $3.97. Cargo Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-4.62. Therefore, Cargo Therapeutics's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-14), Cargo Therapeutics's share price is $3.97. Cargo Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in was $-3.65. Therefore, Cargo Therapeutics's PE Ratio without NRI for today is At Loss.


Cargo Therapeutics Price-to-Owner-Earnings Historical Data

The historical data trend for Cargo Therapeutics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cargo Therapeutics Price-to-Owner-Earnings Chart

Cargo Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
- - - -

Cargo Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cargo Therapeutics's Price-to-Owner-Earnings

For the Biotechnology subindustry, Cargo Therapeutics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cargo Therapeutics's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cargo Therapeutics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cargo Therapeutics's Price-to-Owner-Earnings falls into.


;
;

Cargo Therapeutics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cargo Therapeutics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=3.97/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cargo Therapeutics  (NAS:CRGX) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Cargo Therapeutics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Cargo Therapeutics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Cargo Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.